Funding Postauthorization Vaccine-Safety Science
New England Journal of Medicine · 2024
DOI: 10.1056/nejmp2402379 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Daniel A Salmon und 3 weiteren Autor:innen. Beteiligte Einrichtung: From the Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore (D.A.S.); Emory University, Atlanta (W.O.); the Uni…. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Financing, Government, Product Surveillance, Postmarketing. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore (D.A.S.); Emory University, Atlanta (W.O.); the University of Pennsylvania, Philadelphia (S.A.P.); and the Brighton Colla…
Zitieren
APA
Salmon, D. A., Orenstein, W. A., Plotkin, S. A., & Chen, R. T. (2024). Funding Postauthorization Vaccine-Safety Science. New England Journal of Medicine. https://doi.org/10.1056/nejmp2402379
Vancouver
Salmon DA, Orenstein WA, Plotkin SA, Chen RT. Funding Postauthorization Vaccine-Safety Science. New England Journal of Medicine. 2024. doi:10.1056/nejmp2402379
BibTeX
@article{Salmon2024,
author = {Salmon, Daniel A and Orenstein, Walter A and Plotkin, Stanley A and Chen, Robert T},
title = {Funding Postauthorization Vaccine-Safety Science},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmp2402379}
}
EUVIMED